111 Total Current Liabilities 2018-2024 | YI

111 total current liabilities from 2018 to 2024. Total current liabilities can be defined as the sum of all liabilities classified as current for having maturities of less than one year.
111 Annual Total Current Liabilities
(Millions of US $)
2023 $387
2022 $395
2021 $334
2020 $250
2019 $111
2018 $46
2017 $30
111 Quarterly Total Current Liabilities
(Millions of US $)
2024-06-30 $341
2024-03-31 $358
2023-12-31 $387
2023-09-30 $409
2023-06-30 $320
2023-03-31 $364
2022-12-31 $395
2022-09-30 $317
2022-06-30 $336
2022-03-31 $328
2021-12-31 $334
2021-09-30 $316
2021-06-30 $321
2021-03-31 $267
2020-12-31 $250
2020-09-30 $261
2020-06-30 $175
2020-03-31 $129
2019-12-31 $111
2019-09-30 $93
2019-06-30 $96
2019-03-31 $69
2018-09-30 $52
2017-12-31 $30
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.051B $2.105B
111, Inc. operates as a digital and mobile healthcare platform. The Company offers pharmacy distribution, medical consultancy, e-prescription and other services. 111, Inc. is headquartered in Shanghai, China.
Stock Name Country Market Cap PE Ratio
GE HealthCare Technologies (GEHC) United States $40.428B 21.75
Tempus AI (TEM) United States $7.918B 0.00
Inspire Medical Systems (INSP) United States $6.215B 1157.72
Axonics (AXNX) United States $3.513B 0.00
Hims & Hers Health (HIMS) United States $3.503B 203.88
10x Genomics (TXG) United States $2.660B 0.00
Enovis (ENOV) United States $2.437B 17.67
Azenta (AZTA) United States $2.413B 137.03
Privia Health (PRVA) United States $2.280B 158.92
IRhythm Technologies (IRTC) United States $2.219B 0.00
Omnicell (OMCL) United States $1.968B 64.82
Clover Health Investments (CLOV) United States $1.492B 0.00
Schrodinger (SDGR) United States $1.436B 0.00
Phreesia (PHR) United States $1.389B 0.00
Standard BioTools (LAB) United States $0.753B 0.00
Fulgent Genetics (FLGT) United States $0.694B 0.00
Definitive Healthcare (DH) United States $0.538B 456.00
Health Catalyst (HCAT) United States $0.529B 0.00
Butterfly Network (BFLY) United States $0.406B 0.00
Talkspace (TALK) United States $0.343B 0.00
Pulmonx (LUNG) United States $0.329B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.286B 0.00
TruBridge (TBRG) United States $0.183B 13.44
P3 Health Partners (PIII) United States $0.165B 0.00
American Well (AMWL) United States $0.147B 0.00
Augmedix (AUGX) United States $0.115B 0.00
EUDA Health Holdings (EUDA) Singapore $0.090B 0.00
Future Health ESG (FHLT) United States $0.065B 0.00
SHL Telemedicine (SHLT) Israel $0.055B 0.00
HeartBeam (BEAT) United States $0.053B 0.00
Zepp Health (ZEPP) China $0.049B 0.00
CareCloud (CCLD) United States $0.045B 0.00
Movano (MOVE) United States $0.036B 0.00
Outset Medical (OM) United States $0.034B 0.00
MSP Recovery (LIFW) United States $0.025B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.024B 0.00
Bullfrog AI Holdings (BFRG) United States $0.018B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.018B 0.00
Strata Skin Sciences (SSKN) United States $0.012B 0.00
Streamline Health Solutions (STRM) United States $0.011B 0.00
Precipio (PRPO) United States $0.009B 0.00
Predictive Oncology (POAI) United States $0.006B 0.00
Zhongchao (ZCMD) China $0.003B 0.00
HeartSciences (HSCS) United States $0.003B 0.00
Syra Health (SYRA) United States $0.003B 0.00
Healthcare Triangle (HCTI) United States $0.002B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00